Skip to main content
. 2020 Jul 9;11(18):5289–5292. doi: 10.7150/jca.49462

Figure 1.

Figure 1

Expression of angiotensin-converting enzyme 2 (ACE2) in non-small cell lung cancer (NSCLC). A) The median ACE2 expression of tumor (red) and normal (green) samples in bodymap (Log2 (TPM + 1) Scale, the color depth indicates the degree of ACE2 expression). B) Summary of ACE2 expression in tumor and normal tissues of lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). ACE2 expression in different pathological stages of C) LUAD and D) LUSC.